Supplementary Figure 1 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes

Raffaele De Palma,Ilaria Marigo,Francesco Del Galdo,Carmela De Santo,Paolo Serafini,Sara Cingarlini,Thomas Tüting, Julia Lenz,Giuseppe Basso, Gabriella Milan,Paola Zanovello,Vincenzo Bronte

crossref（2023）

引用 0|浏览7

暂无评分

摘要

Supplementary Figure 1 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8⁺ T Lymphocytes

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 1 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8&lt;sup&gt;+&lt;/sup&gt; T Lymphocytes

Supplementary Figure 1 from Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8<sup>+</sup> T Lymphocytes